Valeo Pharma Inc
TSX:VPH
Valeo Pharma Inc
PP&E Net
Valeo Pharma Inc
PP&E Net Peer Comparison
Competitive PP&E Net Analysis
Latest Figures & CAGR of Competitors
Company | PP&E Net | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Valeo Pharma Inc
TSX:VPH
|
PP&E Net
CA$2.7m
|
CAGR 3-Years
64%
|
CAGR 5-Years
54%
|
CAGR 10-Years
N/A
|
|
Theratechnologies Inc
TSX:TH
|
PP&E Net
$1.8m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
18%
|
CAGR 10-Years
25%
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
PP&E Net
CA$21.5m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
64%
|
CAGR 10-Years
N/A
|
Spectral Medical Inc
TSX:EDT
|
PP&E Net
CA$850k
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
4%
|
|
Cipher Pharmaceuticals Inc
TSX:CPH
|
PP&E Net
$377k
|
CAGR 3-Years
-41%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
N/A
|
|
B
|
BioNxt Solutions Inc
CNSX:BNXT
|
PP&E Net
CA$548.5k
|
CAGR 3-Years
-53%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Valeo Pharma Inc's PP&E Net?
PP&E Net
2.7m
CAD
Based on the financial report for Oct 31, 2023, Valeo Pharma Inc's PP&E Net amounts to 2.7m CAD.
What is Valeo Pharma Inc's PP&E Net growth rate?
PP&E Net CAGR 5Y
54%
Over the last year, the PP&E Net growth was 18%. The average annual PP&E Net growth rates for Valeo Pharma Inc have been 64% over the past three years , 54% over the past five years .